Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robledo

Showing results (141-150 of 215) with videos related to

Pageof 22
Sort By:
Cancer Research|October 3, 2007
Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinomaSergio Ruiz-Llorente, Cristina Montero-Conde, Roger L Milne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2015
DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic MarkersAguirre A de Cubas, Esther Korpershoek, Lucia Inglada-Pérez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2016
Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral NeuropathyMaría Apellániz-Ruiz, Héctor Tejero, Lucía Inglada-Pérez, et al.
European Journal of Endocrinology|November 10, 2023
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort studyAlessa Fischer, Simon Kloos, Hanna Remde, et al.
International Journal of Cancer|July 24, 2019
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinomaJuan M Roldan-Romero, Benoit Beuselinck, María Santos, et al.
Journal of Endocrinological Investigation|December 5, 2024
Genetics of urinary bladder paragangliomas: a multi-center study of a Chinese cohortJingjing Jiang, Yingxian Pang, Rongkui Luo, et al.
Endocrine-Related Cancer|October 28, 2020
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomasNicole Bechmann, Mats Leif Moskopp, Martin Ullrich, et al.
Human Molecular Genetics|December 17, 2013
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomasLuis Jaime Castro-Vega, Alexandre Buffet, Aguirre A De Cubas, et al.
Endocrine-Related Cancer|May 11, 2013
Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathwaysAguirre A de Cubas, L Javier Leandro-García, Francesca Schiavi, et al.
The Journal of Pathology|May 29, 2020
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomasPaal W Wallace, Catleen Conrad, Sascha Brückmann, et al.
Pageof 22

Showing results (141-150 of 215) with videos related to

Sort By:
Pageof 22
Cancer Research|October 3, 2007
Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinomaSergio Ruiz-Llorente, Cristina Montero-Conde, Roger L Milne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2015
DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic MarkersAguirre A de Cubas, Esther Korpershoek, Lucia Inglada-Pérez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2016
Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral NeuropathyMaría Apellániz-Ruiz, Héctor Tejero, Lucía Inglada-Pérez, et al.
European Journal of Endocrinology|November 10, 2023
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort studyAlessa Fischer, Simon Kloos, Hanna Remde, et al.
International Journal of Cancer|July 24, 2019
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinomaJuan M Roldan-Romero, Benoit Beuselinck, María Santos, et al.
Journal of Endocrinological Investigation|December 5, 2024
Genetics of urinary bladder paragangliomas: a multi-center study of a Chinese cohortJingjing Jiang, Yingxian Pang, Rongkui Luo, et al.
Endocrine-Related Cancer|October 28, 2020
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomasNicole Bechmann, Mats Leif Moskopp, Martin Ullrich, et al.
Human Molecular Genetics|December 17, 2013
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomasLuis Jaime Castro-Vega, Alexandre Buffet, Aguirre A De Cubas, et al.
Endocrine-Related Cancer|May 11, 2013
Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathwaysAguirre A de Cubas, L Javier Leandro-García, Francesca Schiavi, et al.
The Journal of Pathology|May 29, 2020
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomasPaal W Wallace, Catleen Conrad, Sascha Brückmann, et al.
Pageof 22